References
1. Phelan AL, Katz R, Gostin LO. The Novel Coronavirus Originating in
Wuhan, China: Challenges for Global Health Governance. Jama.2020.
2. de Groot RJ, Baker SC, Baric RS, et al. Middle East respiratory
syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study
Group. Journal of virology. 2013;87(14):7790-7792.
3. Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic
coronaviruses. Nature reviews Microbiology. 2019;17(3):181-192.
4. Huang C, Wang Y, Li X, et al. Clinical features of patients infected
with 2019 novel coronavirus in Wuhan, China. Lancet.2020;395(10223):497-506.
5. Bai Y, Yao L, Wei T, et al. Presumed Asymptomatic Carrier
Transmission of COVID-19. Jama. 2020;323(14):1406-1407.
6. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical
characteristics of 99 cases of 2019 novel coronavirus pneumonia in
Wuhan, China: a descriptive study. The Lancet.2020;395(10223):507-513.
7. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138
Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in
Wuhan, China. JAMA. 2020;323(11):1061-1069.
8. Wang P, Lu J, Jin Y, Zhu M, Wang L, Chen S. Epidemiological
characteristics of 1212 COVID-19 patients in Henan, China.medRxiv. 2020:2020.2002.2021.20026112.
9. Jin Y-H, Cai L, Cheng Z-S, et al. A rapid advice guideline for the
diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected
pneumonia (standard version). Military Medical Research.2020;7(1):4.
10. Tabata S, Imai K, Kawano S, et al. The clinical characteristics of
COVID-19: a retrospective analysis of 104 patients from the outbreak on
board the Diamond Princess cruise ship in Japan. medRxiv.2020:2020.2003.2018.20038125.
11. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al.
Clinical, laboratory and imaging features of COVID-19: A systematic
review and meta-analysis. Travel Medicine and Infectious Disease.2020;34:101623.
12. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of
critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a
single-centered, retrospective, observational study. Lancet Respir
Med. 2020;8(5):475-481.
13. Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of
2019-nCoV on the epithelial cells of oral mucosa. International
Journal of Oral Science. 2020;12(1):8.
14. Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity
of COVID-19: a descriptive and predictive study. Signal Transduct
Target Ther. 2020;5:33.
15. Liao YC, Liang WG, Chen FW, Hsu JH, Yang JJ, Chang MS. IL-19 induces
production of IL-6 and TNF-alpha and results in cell apoptosis through
TNF-alpha. J Immunol. 2002;169(8):4288-4297.
16. Fischer K, Hoffmann P, Voelkl S, et al. Inhibitory effect of tumor
cell-derived lactic acid on human T cells. Blood.2007;109(9):3812-3819.
17. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19
associated with acute respiratory distress syndrome. Lancet Respir
Med. 2020;8(4):420-422.
18. Bermejo-Martin JF, Martín-Fernandez M, López-Mestanza C, Duque P,
Almansa R. Shared Features of Endothelial Dysfunction between Sepsis and
Its Preceding Risk Factors (Aging and Chronic Disease). J Clin
Med. 2018;7(11).
19. Ai T, Yang Z, Hou H, et al. Correlation of Chest CT and RT-PCR
Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of
1014 Cases. Radiology. 2020:200642.
20. Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J. Chest CT for Typical
2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing.Radiology. 2020:200343.
21. Huang P, Liu T, Huang L, et al. Use of Chest CT in Combination with
Negative RT-PCR Assay for the 2019 Novel Coronavirus but High Clinical
Suspicion. Radiology. 2020;295(1):22-23.
22. Lee EYP, Ng M-Y, Khong P-L. COVID-19 pneumonia: what has CT taught
us? The Lancet Infectious Diseases. 2020;20(4):384-385.
23. Chung M, Bernheim A, Mei X, et al. CT Imaging Features of 2019 Novel
Coronavirus (2019-nCoV). Radiology. 2020;295(1):202-207.
24. Koo HJ, Lim S, Choe J, Choi S-H, Sung H, Do K-H. Radiographic and CT
Features of Viral Pneumonia. RadioGraphics. 2018;38(3):719-739.
25. Arab-Mazar Z, Sah R, Rabaan AA, Dhama K, Rodriguez-Morales AJ.
Mapping the incidence of the COVID-19 hotspot in Iran - Implications for
Travellers. Travel medicine and infectious disease.2020;34:101630-101630.
26. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for
mortality of adult inpatients with COVID-19 in Wuhan, China: a
retrospective cohort study. Lancet. 2020;395(10229):1054-1062.
27. Rahimzadeh G, Ekrami Noghabi M, Kadkhodaei Elyaderani F, et al.
COVID-19 Infection in Iranian Children: A Case Series of 9 Patients.Journal of Pediatrics Review. 2020;8(2):139-144.
28. Zheng Y, Huang Z, Ying G, et al. Study of the lymphocyte change
between COVID-19 and non-COVID-19 pneumonia cases suggesting other
factors besides uncontrolled inflammation contributed to multi-organ
injury. medRxiv. 2020:2020.2002.2019.20024885.
29. Zhang G, Hu C, Luo L, et al. Clinical features and outcomes of 221
patients with COVID-19 in Wuhan, China. medRxiv.2020:2020.2003.2002.20030452.
30. Zhao W, Yu S, Zha X, et al. Clinical characteristics and durations
of hospitalized patients with COVID-19 in Beijing: a retrospective
cohort study. medRxiv. 2020:2020.2003.2013.20035436.
31. Bermejo-Martin JF, Almansa R, Menéndez R, Mendez R, Kelvin DJ,
Torres A. Lymphopenic community acquired pneumonia as signature of
severe COVID-19 infection. The Journal of infection.2020;80(5):e23-e24.
32. Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity
of COVID-19: a descriptive and predictive study. Signal Transduct
Target Ther. 2020;5(1):33-33.
33. Zheng Y, Huang Z, Ying G, et al. Study of the lymphocyte change
between COVID-19 and non-COVID-19 pneumonia cases suggesting other
factors besides uncontrolled inflammation contributed to multi-organ
injury. In: medRxiv; 2020.
34. Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers
associated with COVID-19 disease progression. Crit Rev Clin Lab
Sci. 2020;57(6):389-399.
35. Zeng F, Huang Y, Guo Y, et al. Association of inflammatory markers
with the severity of COVID-19: A meta-analysis. International
Journal of Infectious Diseases. 2020;96:467-474.
36. Shenglan P, Xiangyan Z, Daishun L, Baning Y, Jianquan L.Research Square. 2020.
37. Peng L, Liu K-Y, Xue F, Miao Y-F, Tu P-A, Zhou C. Improved Early
Recognition of Coronavirus Disease-2019 (COVID-19): Single-Center Data
from a Shanghai Screening Hospital. Arch Iran Med.2020;23(4):272-276.
38. Yuan H CX, Ji X, Du F, Zhou X, He J, et al. A Current emerging
respiratory infection: Epidemiological and clinical characteristics,
diagnosis and treatments of COVID-19. . Diagnosis and Treatments
of COVID-19. (3/6/2020)2020.
39. Yang W, Cao Q, Qin L, et al. Clinical characteristics and imaging
manifestations of the 2019 novel coronavirus disease (COVID-19):A
multi-center study in Wenzhou city, Zhejiang, China. Journal of
Infection. 2020;80(4):388-393.
40. Pan F, Ye T, Sun P, et al. Time Course of Lung Changes at Chest CT
during Recovery from Coronavirus Disease 2019 (COVID-19).Radiology. 2020;295(3):715-721.
41. Ng M-Y, Lee EYP, Yang J, et al. Imaging Profile of the COVID-19
Infection: Radiologic Findings and Literature Review. Radiology:
Cardiothoracic Imaging. 2020;2(1):e200034.
42. Stojkovic Lalosevic M, Pavlovic Markovic A, Stankovic S, et al.
Combined Diagnostic Efficacy of Neutrophil-to-Lymphocyte Ratio (NLR),
Platelet-to-Lymphocyte Ratio (PLR), and Mean Platelet Volume (MPV) as
Biomarkers of Systemic Inflammation in the Diagnosis of Colorectal
Cancer. Dis Markers. 2019;2019:6036979-6036979.
43. Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The
Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic
Diseases. Ann Lab Med. 2019;39(4):345-357.
44. Qu R, Ling Y, Zhang Y-h-z, et al. Platelet-to-lymphocyte ratio is
associated with prognosis in patients with coronavirus disease-19.Journal of Medical Virology. 2020;n/a(n/a).
45. Zhao W, Yu S, Zha X, et al. Clinical characteristics and durations
of hospitalized patients with COVID-19 in Beijing: a retrospective
cohort study. In: medRxiv; 2020.
46. Tahamtan A, Ardebili A. Real-time RT-PCR in COVID-19 detection:
issues affecting the results. Expert Rev Mol Diagn.2020;20(5):453-454.
47. Sethuraman N, Jeremiah SS, Ryo A. Interpreting Diagnostic Tests for
SARS-CoV-2. JAMA. 2020;323(22):2249-2251.
Tables :
Table 1: Characteristics and clinical data of the included patients